Comparison of the ion channel characteristics of proapoptotic BAX and antiapoptotic BCL-2.
暂无分享,去创建一个
G Waksman | S. Korsmeyer | G. Waksman | M. Saito | P. Schlesinger | Xiao-Ming Yin | A. Gross | S. Korsmeyer | A. Gross | K. Yamamoto | S J Korsmeyer | Kazuhito Yamamoto | K Yamamoto | P H Schlesinger | A Gross | X M Yin | M Saito | X. Yin
[1] S. Korsmeyer,et al. Bcl-2 and Bax function independently to regulate cell death , 1997, Nature Genetics.
[2] F Gambale,et al. Inhibition of Bax channel-forming activity by Bcl-2. , 1997, Science.
[3] J C Reed,et al. Channel formation by antiapoptotic protein Bcl-2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[4] R. Meadows,et al. Structure of Bcl-xL-Bak Peptide Complex: Recognition Between Regulators of Apoptosis , 1997, Science.
[5] Andy J. Minn,et al. Bcl-xL forms an ion channel in synthetic lipid membranes , 1997, Nature.
[6] J. Xiang,et al. BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[7] C. Milliman,et al. BID: a novel BH3 domain-only death agonist. , 1996, Genes & development.
[8] D. Andrews,et al. Bcl‐2 mutants with restricted subcellular location reveal spatially distinct pathways for apoptosis in different cell types. , 1996, The EMBO journal.
[9] S. Korsmeyer,et al. Fas-induced Activation of the Cell Death-related Protease CPP32 Is Inhibited by Bcl-2 and by ICE Family Protease Inhibitors* , 1996, The Journal of Biological Chemistry.
[10] Xiaodong Wang,et al. Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c , 1996, Cell.
[11] R. Meadows,et al. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death , 1996, Nature.
[12] J. Hunter,et al. A Peptide Sequence from Bax That Converts Bcl-2 into an Activator of Apoptosis (*) , 1996, The Journal of Biological Chemistry.
[13] G. Kroemer,et al. Mitochondrial control of nuclear apoptosis , 1996, The Journal of experimental medicine.
[14] A. Chinnaiyan,et al. Molecular Ordering of the Cell Death Pathway , 1996, The Journal of Biological Chemistry.
[15] E. Cheng,et al. Bax-independent inhibition of apoptosis by Bcl-XL , 1996, Nature.
[16] S. Farrow,et al. New members of the Bcl-2 family and their protein partners. , 1996, Current opinion in genetics & development.
[17] P. Branton,et al. Bcl-2 and adenovirus E1B 19 kDA protein prevent E1A-induced processing of CPP32 and cleavage of poly(ADP-ribose) polymerase. , 1996, Oncogene.
[18] T. Chittenden,et al. A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions. , 1995, The EMBO journal.
[19] Z. Oltvai,et al. Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[20] R. Stroud. Ion channel forming colicins. , 1995, Current opinion in structural biology.
[21] M. Zoratti,et al. The mitochondrial permeability transition. , 1995, Biochimica et biophysica acta.
[22] J. Mindell,et al. Mutational analysis of the helical hairpin region of diphtheria toxin transmembrane domain. , 1994, The Journal of biological chemistry.
[23] R. Benz,et al. Permeation of hydrophilic solutes through mitochondrial outer membranes: review on mitochondrial porins. , 1994, Biochimica et biophysica acta.
[24] Z. Oltvai,et al. Role of membrane anchor domain of Bcl-2 in suppression of apoptosis caused by E1B-defective adenovirus. , 1994, The Journal of biological chemistry.
[25] Z. Oltvai,et al. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax , 1994, Nature.
[26] D. de Jong,et al. Subcellular localization of the bcl-2 protein in malignant and normal lymphoid cells. , 1994, Cancer research.
[27] S. Korsmeyer,et al. Targeting of Bcl-2 to the mitochondrial outer membrane by a COOH-terminal signal anchor sequence. , 1993, The Journal of biological chemistry.
[28] Z. Oltvai,et al. Bcl-2 functions in an antioxidant pathway to prevent apoptosis , 1993, Cell.
[29] John Calvin Reed,et al. Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. , 1993, Cancer research.
[30] S. Korsmeyer,et al. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death , 1993, Cell.
[31] John Calvin Reed,et al. Structure-function analysis of the Bcl-2 oncoprotein. Addition of a heterologous transmembrane domain to portions of the Bcl-2 beta protein restores function as a regulator of cell survival. , 1993, The Journal of biological chemistry.
[32] W. Rocque,et al. Effects of pH on bacterial porin function. , 1992, Biochemistry.
[33] Katherine A. Kantardjieff,et al. The crystal structure of diphtheria toxin , 1992, Nature.
[34] R. J. Collier,et al. Locating a residue in the diphtheria toxin channel. , 1992, Biophysical journal.
[35] K. Sharp,et al. Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons , 1991, Proteins.
[36] M. Zoratti,et al. The giant channel of the inner mitochondrial membrane is inhibited by cyclosporin A. , 1991, The Journal of biological chemistry.
[37] R. Schreiber,et al. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death , 1990, Nature.
[38] K. Hagino-Yamagishi,et al. [Oncogene]. , 2019, Gan to kagaku ryoho. Cancer & chemotherapy.